Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 9/20 | 0.43 |
| ▸ | GAA | P10253 | 8/20 | 0.43 |
| ▸ | MAPT | P10636 | 8/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | SNCA | P37840 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17363623 | 0.80 | MAPT (0.34) | MAPT | |
| Hydrochloric Acid SCHEMBL4227553 | 0.79 | MAPT (0.34) | MAPT | |
| SCHEMBL87790 | 0.76 | GAA (0.47) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL7790923 | 0.76 | NOX1 (0.52) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL563959 | 0.72 | GAA (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433635 | 0.68 | MAPT (0.39) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434466 | 0.68 | MAPT (0.46) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL2536442 | 0.68 | NOX1 (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433232 | 0.68 | NOX1 (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL1201818 | 0.67 | L3MBTL1 (0.45) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988418-B2 | Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-06-05 | — | — | US | disclosed |
| US-20150376230-A1 | METHODS FOR REDUCING AGGREGATE LEVELS IN PROTEIN PREPARATIONS BY TREATMENT WITH THIO-HETEROCYCLIC CATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376230-A1 | METHODS FOR REDUCING AGGREGATE LEVELS IN PROTEIN PREPARATIONS BY TREATMENT WITH THIO-HETEROCYCLIC CATIONS | HTT, TIA1, TTR | NOX1 3376/4885GAA 3148/4885MAPT 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.